« Previous
Next »
Journal of Pain and Symptom Management
Volume 40, Issue 6
, Pages
883-891
, December 2010
Pilot Trial of a Patient-Specific Cutaneous Electrostimulation Device (MC5-A Calmare®) for Chemotherapy-Induced Peripheral Neuropathy
-
The MC5-A Calmare® device positioned to treat stocking-glove neuropathy.
The MC5-A Calmare® device positioned to treat stocking-glove neuropathy.
-
Effect of MC5-A Calmare® therapy on pain scores during treatment. P
<0.0001 by paired t-test, two-tailed.Effect of MC5-A Calmare® therapy on pain scores during treatment. P
<0.0001 by paired t-test, two-tailed. -
Effect of MC5-A Calmare® therapy on pain scores. Overall reduction in pain score is 64%; P
<0.001 by repeated-measures analysis of variance.Effect of MC5-A Calmare® therapy on pain scores. Overall reduction in pain score is 64%; P
<0.001 by repeated-measures analysis of variance. -
Duration of effect of MC5-A Calmare® therapy on pain scores: pain relief over time.
Duration of effect of MC5-A Calmare® therapy on pain scores: pain relief over time.
PII: S0885-3924(10)00521-X
doi: 10.1016/j.jpainsymman.2010.03.022
« Previous
Next »
Journal of Pain and Symptom Management
Volume 40, Issue 6
, Pages
883-891
, December 2010
